blindness
The test, which detects circulating cell-free DNA in urine samples, may help in reaching World Health Organization elimination goals.
DCN Dx, BIOASTER Collaborate for Neglected Tropical Disease Multiplex Assays
The firms will develop a multiplexed lateral flow test to detect the parasites causing river blindness.
Quest Diagnostics Acquires Blueprint Genetics
Blueprint provides 3,900 targeted single-gene and more than 200 panel tests covering 14 medical specialties, leveraging NGS and bioinformatics methods.
The company announced this week the expansion of a genetic testing program for US patients with inherited retinal disease that it has run with partners since 2017.
Q BioMed Licenses Glaucoma Biomarker From WUSTL
The firm said that expression levels of GDF15 can be used to determine the severity of glaucoma, one of the leading causes of blindness.